Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10.
about
The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.Immunization of mice with YscF provides protection from Yersinia pestis infectionsYscP of Yersinia pestis is a secreted component of the Yop secretion systemMulti-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative BacteriaLcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanismVirulence role of V antigen of Yersinia pestis at the bacterial surface.In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.The role of relA and spoT in Yersinia pestis KIM5 pathogenicityAmino acid and structural variability of Yersinia pestis LcrV protein.Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopesHijacking of the pleiotropic cytokine interferon-γ by the type III secretion system of Yersinia pestisAnti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.Kinetics of disease progression and host response in a rat model of bubonic plague.Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen)Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice.Development of in vitro correlate assays of immunity to infection with Yersinia pestis.Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestisYersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppressionRecombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection.The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cellsSubstrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient micePlague vaccines: current developments and future perspectives.YopK regulates the Yersinia pestis type III secretion system from within host cells.Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model.Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
P2860
Q24521130-0FA55FEC-F831-4A1A-AAF4-F4EFDD262572Q24815169-A5953798-7977-41BA-B2B2-4A18CBE14FCBQ28492821-761740C4-71B2-42FF-8896-287087E1C3B0Q30431366-F6315D2F-16E1-4A91-BE4D-071806F843ADQ30756919-70DB1C6B-FF22-4BB4-8F04-43809147E83CQ30778457-BECBF5D6-235B-4D74-970F-A2D9C0F8B33CQ33483363-F982A8EB-0EBE-4F16-97DE-318A08BA7737Q33496136-D0A8EFD8-3518-4906-BBFA-624728CAC25CQ33636983-C2F17BAA-985B-4CD3-A87C-75E7335C04FDQ33675781-A68B10DC-6FE4-4E01-917E-81B18814D515Q33716043-5CBDB812-A714-42CE-B93D-CDA5C8725E4AQ33750146-4DC711E2-2FA1-418E-8913-17BDD15FF945Q33778441-FB734FD9-9CC2-48ED-8D46-4F57F41D96BEQ34034184-F60AECA8-E1F5-4858-A191-1FE264C6E3C5Q34115870-99377B8D-FE78-4176-B8D7-0405B7386713Q34778198-A4E059BF-4F8B-4827-A3D3-CFE4BEDFE8A6Q35087782-7C5BC800-CC0A-49A2-AA88-0EA9892C18BCQ35159314-DBB202C3-11C2-4E9E-826E-40CABE3C2D94Q35671570-7BE2BBF4-0C33-40F8-A1A8-D4BFAF99D4A6Q35783560-60841280-BE15-44DB-B765-4C8C76DBA9C0Q35913680-404398D3-22B9-4CD6-9F6D-4A8B8E68C4F5Q36155982-D5729A3A-CB6E-4E02-8B67-FF70BE262824Q36237899-A5BC5DB4-333B-4227-B094-9286543643F9Q36315395-DD5D94E2-09AD-47DB-BA10-55217F24E2C1Q36371199-E89F7898-4E31-4EA1-8A39-D2812700B24BQ36373952-8B4998B6-3FCE-4B4F-BF76-E959A26E1CDFQ36445138-0D5448DC-FA84-4793-BF5A-924DE7F7466CQ37033094-F6AF6AF9-929F-4CE5-8BB3-9FD302CF59A7Q38514208-55E278E2-BEDA-4474-80E5-60E04D7D6E80Q38984442-9F749FB3-9DDA-49BC-9D8B-2E5921F53FA5Q39180064-4FC031BF-B37E-4FF8-8CC5-5221823E2518Q41408850-403CF848-C3B0-4912-88E2-B528423E6F9BQ41452967-580D9C1B-23D0-478C-8ADA-FFF221BCCED4
P2860
Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Resistance to lipopolysacchari ...... plification of interleukin-10.
@ast
Resistance to lipopolysacchari ...... plification of interleukin-10.
@en
type
label
Resistance to lipopolysacchari ...... plification of interleukin-10.
@ast
Resistance to lipopolysacchari ...... plification of interleukin-10.
@en
prefLabel
Resistance to lipopolysacchari ...... plification of interleukin-10.
@ast
Resistance to lipopolysacchari ...... plification of interleukin-10.
@en
P2093
P2860
P1476
Resistance to lipopolysacchari ...... mplification of interleukin-10
@en
P2093
Brubaker RR
Nedialkov YA
P2860
P304
P407
P577
1997-04-01T00:00:00Z